Decreased inhibitory activity of PKC in OCD patients after six months of treatment

Psychoneuroendocrinology

Volumn 27, Issue 7, 2002, Pages 769-776

  Marazziti, Donatella ^a   Dell'Osso, Liliana ^a   Masala, Irene ^a   Baroni, Stefano ^a   Presta, Silvio ^a   Giannaccini, Gino ^a   Di Nasso, Elena ^a   Mungai, Francesco ^a   Lucacchini, Antonio ^a   Cassano, Giovanni B ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Obsessive compulsive disorder; Phosphatidylinositol 4,5 biphosphate; Protein kinase C; Second messengers; Serotonin; Serotonin transporter

Indexed keywords

4 BETA 12 TETRADECANOYLPHORBOL 13 ACETATE; CITALOPRAM; CLOMIPRAMINE; FLUVOXAMINE; PAROXETINE; PHORBOL ESTER; PROTEIN KINASE C; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; HUMAN; MALE; MICHAELIS CONSTANT; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SCHOOL CHILD; SECOND MESSENGER; SEROTONIN UPTAKE;

ADOLESCENT; ADULT; BLOOD PLATELETS; CHILD; ENZYME INHIBITORS; FEMALE; HUMANS; KINETICS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PROTEIN KINASE C; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TETRADECANOYLPHORBOL ACETATE;

EID: 0036808865     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(01)00076-2     Document Type: Article

References (36)

1. Anderson, G., Horne, W.C., 1992. Activators of protein kinase C decrease serotonin transport in human platelets. Biochem. Biophys. Acta 1137, 331-333.
2. Arora, R.C., Meltzer, H.Y., 1981. A modified assay method for determining serotonin uptake in human platelets. Clin. Chim. Acta 112, 223-225.
3. Asberg, M., Thoren, P., Bertilsson, L., 1981. Chlomipramine treatment of obsessive disorder: Biochemical and clinical aspects. Psychopharmacol. Bull. 18, 13-21.
4. Bastani, B., Arora, R.C., Meltzer, H.Y., 1991. Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients. Biol. Psychiatry 30, 131-139.
5. Black, D.W., Kelly, M., Myers, C., Noyes, R. Jr., 1990. Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls. Biol. Psychiatry 27, 319-327.
6. Blakely, R.D., Ramamoorthy, S., Schroeter, S., Qian, Y., Apparsundaram, S., Galli, A., DeFelice, L.J., 1998. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol. Psychiatry 44, 169-178.
7. Fineberg, N., 1996. Refining treatment approaches in obsessive-compulsive disorder. J. Clin. Psychopharmacol. 11 (suppl. 5), 13-22.
8. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., 1997. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0, 4/97 revision). Biometrics Research Department, New York State Psychiatric Institute.
9. Goodman, W.K., Price, L.H., Rasmussen, S.A.K., 1986. The Yale Brown Obsessive-Compulsive Scale I: Development, use and reliability. Arch. Gen. Psychiatry 46, 1006-1011.
10. Greist, J.H., Jefferson, J.W., Kobak, K.H., Katzenlick, D.J., Serlin, R.C., 1995. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch. Gen. Psychiatry 52, 53-60.
11. Hollander, E., Fay, M., Cohen, B., Campeas, R., Gorman, J.M., Liebowitz, M.R., 1988. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: Behavioral findings. Am. J. Psychiatry 145, 1015-1027.
12. 3H imipramine binding in intact human platelets. Biol. Psychiatry 25, 576-584.
13. Insel, T.R., Mueller, E.A., Alterman, I., Linnoila, M., Murphy, D.L., 1985. Obsessive-compulsive disorder and serotonin: Is there a connection? Biol. Psychiatry 120, 1174-1188.
14. Leathebarrow, R.J., 1992. Grafit Version 3.0. Erithacus Software Ltd, Staines, UK.
15. Lesch, K.P., Wolozin, B.L., Murphy, D.L., Riederer, P., 1993. Primary structure of the human platelet serotonin uptake: Identity with the brain serotonin transporter. J. Neurochem. 60, 2319-2322.
16. 3H-hydroxytryptamine uptake in rat diencephalon. J. Neurochem. 59, 1856-1861.
17. Marazziti, D., Hollander, E., Lensi, P., Ravagli, S., Cassano, G.B., 1992. Peripheral marker of serotonin and dopamine function in obsessive-compulsive disorder. Psychiatry Res. 42, 41-51.
18. 3H-paroxetine binding in obsessive-compulsive patients. Neuropsychobiology 34, 184-187.
19. Marazziti, D., Pfanner, C., Palego, L., Gemignani, A., Milanfranchi, A., Ravagli, S., Lensi, P., Presta, S., Cassano, G.B., 1997. Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramine. Pharmacopsychiatry 30, 245-249.
20. Marazziti, D., Rossi, A., Masala, I., Rotondo, A., Palego, L., Mazzoni, M.R., Giannaccini, G., Lucacchini, A., Cassano, G.B., 1999. Regulation of the platelet serotonin transporter by protein kinase C in the young and elderly. Biol. Psychiatry 45, 443-447.
21. Marazziti, D., Masala, I., Rossi, A., Hollander, E., Presta, S., Giannaccini, G., Mazzoni, M.R., Dell'Osso, L., Lucacchini, A., Cassano, G.B., 2000. Increased inhibitory activity of protein kinase C on the serotonin transporter in OCD. Neuropsychobiology 41, 171-177.
22. Marazziti, D., Perez, J., Cassano, G.B., 2001. Is obsessive-compulsive disorder due to a second messenger imbalance? CNS Spectrums 6, 206-209.
23. 3H-imipramine to protease-sensitive and protease-resistant sites. J. Neurochem. 44, 705-711.
24. 3H-imipramine and the serotonin transporter in human platelets. J. Neurochem. 48, 560-565.
25. Montgomery, S.A., 1994. Pharmacological treatment of obsessive-compulsive disorder. In: Hollander, E., Zohar, J., Marazziti, D., Olivier, B.E. (Eds.), Current Insights in Obsessive-Compulsive Disorder. Wiley and Sons, Chichester, UK, pp. 123-137.
26. Perez, J., Tardito, D., Ravizza, L., Racagni, G., Mori, S., Maina, G., 2000. Altered cAMp-dependent protein kinase in platelets of patients with obsessive-compulsive disorder. Am. J. Psychiatry 157, 284-286.
27. Piccinelli, M., Pini, S., Bellantuono, C., Wilkinson, C., 1995. Efficacy of drug treatment in obsessive-compulsive disorder. Br. J. Psychiatry 166, 424-443.
28. Rausch, J.J., Hutchinson, J., Li, X., 1995. Correlations of drug action between human platelets and human brain 5HTT. Biol. Psychiatry (suppl.) 137, 600.
29. Sallee, F.R., Richman, H., Beach, K., Sethuram, G., Nesbitt, L., 1996. Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome. J. Am. Acad. Child Adolesc. Psychiatry 35, 1647-1656.
30. Soares, J.C., Mallinger, A.G., 1997. Intracellular phosphatidylinositol pathway abnormalities in bipolar disorder patients. Psychopharmacol. Bull. 33, 685-691.
31. Thoren, P., Asberg, M., Cronholm, B., 1980. Clomipramine treatment of obsessive-compulsive disorder: A controlled clinical trial. Arch. Gen. Psychiatry 137, 1281-1289.
32. Vitiello, B., Shimon, H., Behar, D., Stoff, D., Bridger, W.H., Friedman, E., 1991. Platelet imipramine binding and serotonin uptake in obsessive-compulsive patients. Acta Psychiat. Scand. 84, 29-32.
33. Wang, H.Y., Friedman, E., 1996. Enhanced protein kinase C activity and translocation in bipolar affective disorders. Biol. Psychiatry 40, 568-575.
34. Weizman, R., Carmi, M., Hermesh, H., Shahar, A., Apter, A., Tyano, S., Rehavi, M., 1986. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients. Am. J. Psychiatry 143, 335-339.
35. Zohar, J., Insel, T.R., 1987. Obsessive-compulsive disorder: Psychobiological approaches to diagnosis, treatment and pathophysiology. Biol. Psychiatry 22, 667-687.
36. Zohar, J., Insel, T.R., Zohar-Kadouch, R.C., Hill, J., Murphy, D.L., 1988. Serotonergic responsivity in obsessive-compulsive disorder. Effect of chronic clomipramine treatment. Arch. Gen. Psychiatry 45, 167-172.